- Human（1）
No data
- His Tag（1）
No data
- E. coli（1）
No data
- Unconjugated（1）
No data
- RUO（1）
No data
- No（1）
No data
- 100ug/$360.00
- 1mg (200ug X 5)/$2380.00
No data
| Molecule | Cat. No. | Product Name | Art | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| CXCL14 | Human CXCL14 Protein, His Tag |  Human | E. coli |  | SDS-PAGE | $360.00 100ug |   |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Bexotegrast | PLN-74809 | Phase 3 Clinical | Pliant Therapeutics Inc | Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Cholangitis, Sclerosing | Details |
| IDL-2965 | IDL-2965 | Phase 2 Clinical | Indalo Therapeutics Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis | Details |
| PLN-1474 | PLN-1474 | Phase 1 Clinical | Pliant Therapeutics Inc, Novartis Pharma Ag | Metabolic Dysfunction-Associated Steatotic Liver Disease; Liver Cirrhosis | Details |
